The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer

Published:2009-07-16 Issue:1 Volume:136 Page:79-88
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Bauerschlag Dirk O.,Schem Christian,Weigel Marion T.,von Kaisenberg Constantin,Strauss Alexander,Bauknecht Thomas,Maass Nicolai,Meinhold-Heerlein Ivo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-009-0639-8.pdf

Reference57 articles.

1. Bali A, O’Brien PM et al (2004) Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Clin Cancer Res 10(15):5168–5177

2. Bartel F, Jung J et al (2008) Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival. Clin Cancer Res 14(1):89–96

3. Bolis G, Scarfone G et al (2001) Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancer. Gynecol Oncol 81(1):3–9

4. Budowle B, Chakraborty R et al (1991) Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 48(1):137–144

5. Chan JK, Teoh D et al (2008) Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 109(3):370–376

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-Generation Sequencing in Gynaecological Tumours: The Prognostic and Predictive Value of the Most Common Mutations Found in Ovarian, Endometrial, and Cervical Tumours: Literature Review and the University Medical Centre Utrecht Next-Generation Sequencing Data;Pathobiology;2017

2. Replicating viruses for gynecologic cancer therapy;EUR J GYNAECOL ONCOL;2016

3. BRCA2 N372H Polymorphism and Risk of Epithelial Ovarian Cancer;Medicine;2015-10

4. Mutant p53 and the Response to Chemotherapy and Radiation;Subcellular Biochemistry;2014

5. The heterogeneity of ovarian cancer;Archives of Gynecology and Obstetrics;2013-12-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3